Sort
40,608 grants matching “prostate cancer”
Androgen Receptor Action in Castration Resistant Prostate Cancer
$2,045,478Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2017 · CA
Androgen Receptor Action in Castration Resistant Prostate Cancer
$2,045,071Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2016 · CA
Washington University Molecular Imaging Center
$2,044,707Washington University · P50 · FY2005 · CA
Consultation and Collaboration
$2,043,593Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Washington University Molecular Imaging Center
$2,042,605David R Piwnica-Worms · Washington University · P50 · FY2006 · CA
Mammary Gland as a Sensitive End Point to Effects of Endocrine Disruptors
$2,040,573Suzanne Fenton · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
Targeting the DNA damage response in cancer therapy
$2,040,170Travis Stracker · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Winship Cancer Institute Cancer Center Support Grant
$2,038,828Walter John Curran · Emory University · P30 · FY2016 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$2,038,418Christian Abnet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
The Role of PTEN and the PI3K Pathway in Prostate Cancer
$2,037,021Lewis C Cantley · Beth Israel Deaconess Medical Center · P01 · FY2011 · CA
Molecular Profiling of Clinical Specimens
$2,032,400Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
DNA Sequencing and FACS Core Facilities
$2,031,947Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Center for Transformative Community-Driven Research to Prevent Obesity-related Cancer
$2,031,039Karen M Basen-Engquist · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
YALE COMPREHENSIVE CANCER CENTER
$2,030,343Yale University · P30 · FY2001 · CA
Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS
$2,029,401Jay A Berzofsky · Clinical Sciences · Z01 · FY2007 · CA
Cancer Epidemiology Cohort in Male Health Professionals
$2,028,788Walter C. Willett · Harvard School Of Public Health · U01 · FY2020 · CA
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?
$2,028,370John M. Sedivy · Brown University · P01 · FY2016 · AG
DENTIFICATION OF EPIGENETICALLY DRIVEN VULNERABILITIES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
$2,028,000Icahn School Of Medicine At Mount Sinai · · FY2025 · Defense Health Agency
Human T-Cell Responses to Tumor Antigens
$2,027,509Jeffrey Schlom · Basic Sciences · Z01 · FY2007 · CA
The Role of PTEN and the PI3K Pathway in Prostate Cancer
$2,026,408Lewis C Cantley · Beth Israel Deaconess Medical Center · P01 · FY2008 · CA
Center for Nutrient-Gene Interaction in Cancer Preventi*
$2,024,315University Of Alabama At Birmingham · U54 · FY2005 · CA
Cancer Risk in Human Populations
$2,021,956Debra Silverman · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Center on the Physics of Cancer Metabolism
$2,021,161Claudia Fischbach · Cornell University · U54 · FY2018 · CA
Androgen Receptor Action in Castration Resistant Prostate Cancer
$2,010,837Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2014 · CA
Mechanisms and Markers of Prostate Cancer Metastases
$2,008,990University Of Washington · P01 · FY2002 · CA